| Product Code: ETC10600303 | Publication Date: Apr 2025 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Human Immunodeficiency Virus Therapeutics Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Human Immunodeficiency Virus Therapeutics Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Human Immunodeficiency Virus Therapeutics Market - Industry Life Cycle |
3.4 Israel Human Immunodeficiency Virus Therapeutics Market - Porter's Five Forces |
3.5 Israel Human Immunodeficiency Virus Therapeutics Market Revenues & Volume Share, By Treatment Class, 2021 & 2031F |
3.6 Israel Human Immunodeficiency Virus Therapeutics Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.7 Israel Human Immunodeficiency Virus Therapeutics Market Revenues & Volume Share, By Formulation Type, 2021 & 2031F |
3.8 Israel Human Immunodeficiency Virus Therapeutics Market Revenues & Volume Share, By Target Population, 2021 & 2031F |
3.9 Israel Human Immunodeficiency Virus Therapeutics Market Revenues & Volume Share, By Therapeutic Area, 2021 & 2031F |
4 Israel Human Immunodeficiency Virus Therapeutics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness and education about HIV/AIDS in Israel |
4.2.2 Technological advancements in HIV therapeutics leading to more effective treatments |
4.2.3 Government initiatives and funding for HIV prevention and treatment programs |
4.3 Market Restraints |
4.3.1 High cost of HIV therapeutics leading to limited access for some patients |
4.3.2 Stigma associated with HIV/AIDS impacting patient willingness to seek treatment |
4.3.3 Regulatory challenges and delays in drug approvals affecting market growth |
5 Israel Human Immunodeficiency Virus Therapeutics Market Trends |
6 Israel Human Immunodeficiency Virus Therapeutics Market, By Types |
6.1 Israel Human Immunodeficiency Virus Therapeutics Market, By Treatment Class |
6.1.1 Overview and Analysis |
6.1.2 Israel Human Immunodeficiency Virus Therapeutics Market Revenues & Volume, By Treatment Class, 2021 - 2031F |
6.1.3 Israel Human Immunodeficiency Virus Therapeutics Market Revenues & Volume, By Antiretrovirals, 2021 - 2031F |
6.1.4 Israel Human Immunodeficiency Virus Therapeutics Market Revenues & Volume, By Protease Inhibitors, 2021 - 2031F |
6.1.5 Israel Human Immunodeficiency Virus Therapeutics Market Revenues & Volume, By Integrase Inhibitors, 2021 - 2031F |
6.1.6 Israel Human Immunodeficiency Virus Therapeutics Market Revenues & Volume, By Reverse Transcriptase Inhibitors, 2021 - 2031F |
6.1.7 Israel Human Immunodeficiency Virus Therapeutics Market Revenues & Volume, By Entry Inhibitors, 2021 - 2031F |
6.2 Israel Human Immunodeficiency Virus Therapeutics Market, By Drug Type |
6.2.1 Overview and Analysis |
6.2.2 Israel Human Immunodeficiency Virus Therapeutics Market Revenues & Volume, By Inhibitors, 2021 - 2031F |
6.2.3 Israel Human Immunodeficiency Virus Therapeutics Market Revenues & Volume, By Combination Therapy, 2021 - 2031F |
6.2.4 Israel Human Immunodeficiency Virus Therapeutics Market Revenues & Volume, By Single Tablet Regimen, 2021 - 2031F |
6.2.5 Israel Human Immunodeficiency Virus Therapeutics Market Revenues & Volume, By Fixed-dose Combinations, 2021 - 2031F |
6.2.6 Israel Human Immunodeficiency Virus Therapeutics Market Revenues & Volume, By Injectable, 2021 - 2031F |
6.3 Israel Human Immunodeficiency Virus Therapeutics Market, By Formulation Type |
6.3.1 Overview and Analysis |
6.3.2 Israel Human Immunodeficiency Virus Therapeutics Market Revenues & Volume, By Oral, 2021 - 2031F |
6.3.3 Israel Human Immunodeficiency Virus Therapeutics Market Revenues & Volume, By Injectable, 2021 - 2031F |
6.3.4 Israel Human Immunodeficiency Virus Therapeutics Market Revenues & Volume, By Injectable/Oral, 2021 - 2031F |
6.3.5 Israel Human Immunodeficiency Virus Therapeutics Market Revenues & Volume, By Oral, 2021 - 2031F |
6.3.6 Israel Human Immunodeficiency Virus Therapeutics Market Revenues & Volume, By Subcutaneous, 2021 - 2031F |
6.4 Israel Human Immunodeficiency Virus Therapeutics Market, By Target Population |
6.4.1 Overview and Analysis |
6.4.2 Israel Human Immunodeficiency Virus Therapeutics Market Revenues & Volume, By Adults, 2021 - 2031F |
6.4.3 Israel Human Immunodeficiency Virus Therapeutics Market Revenues & Volume, By Children, 2021 - 2031F |
6.4.4 Israel Human Immunodeficiency Virus Therapeutics Market Revenues & Volume, By At-Risk Populations, 2021 - 2031F |
6.4.5 Israel Human Immunodeficiency Virus Therapeutics Market Revenues & Volume, By Patients with Low CD4 Count, 2021 - 2031F |
6.4.6 Israel Human Immunodeficiency Virus Therapeutics Market Revenues & Volume, By HIV-Positive Patients, 2021 - 2031F |
6.5 Israel Human Immunodeficiency Virus Therapeutics Market, By Therapeutic Area |
6.5.1 Overview and Analysis |
6.5.2 Israel Human Immunodeficiency Virus Therapeutics Market Revenues & Volume, By HIV/AIDS Treatment, 2021 - 2031F |
6.5.3 Israel Human Immunodeficiency Virus Therapeutics Market Revenues & Volume, By HIV Prevention, 2021 - 2031F |
6.5.4 Israel Human Immunodeficiency Virus Therapeutics Market Revenues & Volume, By Viral Suppression, 2021 - 2031F |
6.5.5 Israel Human Immunodeficiency Virus Therapeutics Market Revenues & Volume, By Early Intervention, 2021 - 2031F |
6.5.6 Israel Human Immunodeficiency Virus Therapeutics Market Revenues & Volume, By Prevention and Treatment, 2021 - 2031F |
7 Israel Human Immunodeficiency Virus Therapeutics Market Import-Export Trade Statistics |
7.1 Israel Human Immunodeficiency Virus Therapeutics Market Export to Major Countries |
7.2 Israel Human Immunodeficiency Virus Therapeutics Market Imports from Major Countries |
8 Israel Human Immunodeficiency Virus Therapeutics Market Key Performance Indicators |
8.1 Number of individuals enrolled in HIV treatment programs |
8.2 Average time to market for new HIV therapeutics in Israel |
8.3 Percentage of HIV-positive individuals with access to antiretroviral therapy |
9 Israel Human Immunodeficiency Virus Therapeutics Market - Opportunity Assessment |
9.1 Israel Human Immunodeficiency Virus Therapeutics Market Opportunity Assessment, By Treatment Class, 2021 & 2031F |
9.2 Israel Human Immunodeficiency Virus Therapeutics Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.3 Israel Human Immunodeficiency Virus Therapeutics Market Opportunity Assessment, By Formulation Type, 2021 & 2031F |
9.4 Israel Human Immunodeficiency Virus Therapeutics Market Opportunity Assessment, By Target Population, 2021 & 2031F |
9.5 Israel Human Immunodeficiency Virus Therapeutics Market Opportunity Assessment, By Therapeutic Area, 2021 & 2031F |
10 Israel Human Immunodeficiency Virus Therapeutics Market - Competitive Landscape |
10.1 Israel Human Immunodeficiency Virus Therapeutics Market Revenue Share, By Companies, 2024 |
10.2 Israel Human Immunodeficiency Virus Therapeutics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here